Journal of Endocrinology

References

1. ↵
   1. Adamson AD,
   2. Friedrichsen S,
   3. Semprini S,
   4. Harper CV,
   5. Mullins JJ,
   6. White MRH &
   7. Davis JRE

   2008 Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-{alpha} signaling. Endocrinology 149 687–694doi:10.1210/en.2007-1066.
2. ↵
   1. Alwine JC,
   2. Kemp DJ &
   3. Stark GR

   1977 Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. PNAS 74 5350–5354doi:10.1073/pnas.74.12.5350.
3. ↵
   1. An JJ,
   2. Cho S-R,
   3. Jeong DW,
   4. Park KW,
   5. Ahn YS &
   6. Baik J-H

   2003 Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells. Molecular and Cellular Endocrinology 206 49–62doi:10.1016/S0303-7207(03)00236-3.
4. ↵
   1. Anastassiadis K,
   2. Kim J,
   3. Daigle N,
   4. Sprengel R,
   5. Schöler HR &
   6. Stewart AF

   2002 A predictable ligand regulated expression strategy for stably integrated transgenes in mammalian cells in culture. Gene 298 159–172doi:10.1016/S0378-1119(02)00979-4.
5. ↵
   1. Archer TK,
   2. Lefebvre P,
   3. Wolford RG &
   4. Hager GL

   1992 Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science 255 1573–1576doi:10.1126/science.1347958.
6. ↵
   1. Archer TK,
   2. Lee HL,
   3. Cordingley MG,
   4. Mymryk JS,
   5. Fragoso G,
   6. Berard DS &
   7. Hager GL

   1994 Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter. Molecular Endocrinology 8 568–576doi:10.1210/me.8.5.568.
7. ↵
   1. Ashall L,
   2. Horton CA,
   3. Nelson DE,
   4. Paszek P,
   5. Harper CV,
   6. Sillitoe K,
   7. Ryan S,
   8. Spiller DG,
   9. Unitt JF,
   10. Broomhead DS
   11. et al.

   2009 Pulsatile stimulation determines timing and specificity of NF-{kappa}B-dependent transcription. Science 324 242–246doi:10.1126/science.1164860.
8. ↵
   1. Baiker A,
   2. Maercker C,
   3. Piechaczek C,
   4. Schmidt SB,
   5. Bode J,
   6. Benham C &
   7. Lipps HJ

   2000 Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix. Nature Cell Biology 2 182–184doi:10.1038/35004061.
9. ↵
   1. Bell AC,
   2. West AG &
   3. Felsenfeld G

   2001 Insulators and boundaries: versatile regulatory elements in the eukaryotic genome. Science 291 447–450doi:10.1126/science.291.5503.447.
10. ↵
    1. Ben-Jonathan N,
    2. LaPensee CR &
    3. LaPensee EW

    2008 What can we learn from rodents about prolactin in humans? Endocrine Reviews 29 1–41doi:10.1210/er.2007-0017.
11. ↵
    1. Bernichtein S,
    2. Touraine P &
    3. Goffin V

    2010 New concepts in prolactin biology. Journal of Endocrinology 206 1–11doi:10.1677/JOE-10-0069.
12. ↵
    1. Bode J,
    2. Kohwi Y,
    3. Dickinson L,
    4. Joh T,
    5. Klehr D,
    6. Mielke C &
    7. Kohwi-Shigematsu T

    1992 Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 255 195–197doi:10.1126/science.1553545.
13. ↵
    1. Bodner M &
    2. Karin M

    1987 A pituitary-specific trans-acting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells. Cell 50 267–275doi:10.1016/0092-8674(87)90222-4.
14. ↵
    1. Brown AM,
    2. Jeltsch JM,
    3. Roberts M &
    4. Chambon P

    1984 Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. PNAS 81 6344–6348doi:10.1073/pnas.81.20.6344.
15. ↵
    1. Carroll JS,
    2. Liu XS,
    3. Brodsky AS,
    4. Li W,
    5. Meyer CA,
    6. Szary AJ,
    7. Eeckhoute J,
    8. Shao W,
    9. Hestermann EV,
    10. Geistlinger TR
    11. et al.

    2005 Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122 33–43doi:10.1016/j.cell.2005.05.008.
16. ↵
    1. Chudakov DM,
    2. Matz MV,
    3. Lukyanov S &
    4. Lukyanov KA

    2010 Fluorescent proteins and their applications in imaging living cells and tissues. Physiological Reviews 90 1103–1163doi:10.1152/physrev.00038.2009.
17. ↵
    1. Conese M,
    2. Auriche C &
    3. Ascenzioni F

    2004 Gene therapy progress and prospects: episomally maintained self-replicating systems. Gene Therapy 11 1735–1741doi:10.1038/sj.gt.3302362.
18. ↵
    1. Conese M,
    2. Boyd AC,
    3. Di Gioia S,
    4. Auriche C &
    5. Ascenzioni F

    2007 Genomic context vectors and artificial chromosomes for cystic fibrosis gene therapy. Current Gene Therapy 7 175–187doi:10.2174/156652307780859026.
19. ↵
    1. Copeland NG,
    2. Jenkins NA &
    3. Court DL

    2001 Recombineering: a powerful new tool for mouse functional genomics. Nature Reviews. Genetics 2 769–779doi:10.1038/35093556.
20. ↵
    1. Cuchet D,
    2. Potel C,
    3. Thomas J &
    4. Epstein AL

    2007 HSV-1 amplicon vectors: a promising and versatile tool for gene delivery. Expert Opinion on Biological Therapy 7 975–995doi:10.1517/14712598.7.7.975.
21. ↵
    1. DeKelver RC,
    2. Choi VM,
    3. Moehle EA,
    4. Paschon DE,
    5. Hockemeyer D,
    6. Meijsing SH,
    7. Sancak Y,
    8. Cui X,
    9. Steine EJ,
    10. Miller JC
    11. et al.

    2010 Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Research 20 1133–1142doi:10.1101/gr.106773.110.
22. ↵
    1. De Lorenzi R,
    2. Gareus R,
    3. Fengler S &
    4. Pasparakis M

    2009 GFP-p65 knock-in mice as a tool to study NF-kappaB dynamics in vivo. Genesis 47 323–329doi:10.1002/dvg.20468.
23. ↵
    1. Dillon N &
    2. Festenstein R

    2002 Unravelling heterochromatin: competition between positive and negative factors regulates accessibility. Trends in Genetics 18 252–258doi:10.1016/S0168-9525(02)02648-3.
24. ↵
    1. Eldar A &
    2. Elowitz MB

    2010 Functional roles for noise in genetic circuits. Nature 467 167–173doi:10.1038/nature09326.
25. ↵
    1. Finkenstädt B,
    2. Heron EA,
    3. Komorowski M,
    4. Edwards K,
    5. Tang S,
    6. Harper CV,
    7. Davis JRE,
    8. White MRH,
    9. Millar AJ &
    10. Rand DA

    2008 Reconstruction of transcriptional dynamics from gene reporter data using differential equations. Bioinformatics 24 2901–2907doi:10.1093/bioinformatics/btn562.
26. ↵
    1. Frawley LS,
    2. Faught WJ,
    3. Nicholson J &
    4. Moomaw B

    1994 Real time measurement of gene expression in living endocrine cells. Endocrinology 135 468–471doi:10.1210/en.135.1.468.
27. ↵
    1. Gallagher PG,
    2. Nilson DG,
    3. Steiner LA,
    4. Maksimova YD,
    5. Lin JY &
    6. Bodine DM

    2009 An insulator with barrier-element activity promotes {alpha}-spectrin gene expression in erythroid cells. Blood 113 1547–1554doi:10.1182/blood-2008-06-164954.
28. ↵
    1. Gariglio P,
    2. Bellard M &
    3. Chambon P

    1981 Clustering of RNA polymerase B molecules in the 5′ moiety of the adult beta-globin gene of hen erythrocytes. Nucleic Acids Research 9 2589–2598doi:10.1093/nar/9.11.2589.
29. ↵
    1. Gavin A-C,
    2. Aloy P,
    3. Grandi P,
    4. Krause R,
    5. Boesche M,
    6. Marzioch M,
    7. Rau C,
    8. Jensen LJ,
    9. Bastuck S,
    10. Dumpelfeld B
    11. et al.

    2006 Proteome survey reveals modularity of the yeast cell machinery. Nature 440 631–636doi:10.1038/nature04532.
30. ↵
    1. Gellersen B,
    2. Kempf R,
    3. Telgmann R &
    4. DiMattia GE

    1995 Pituitary-type transcription of the human prolactin gene in the absence of Pit-1. Molecular Endocrinology 9 887–901doi:10.1210/me.9.7.887.
31. ↵
    1. Gerlo S,
    2. Davis JR,
    3. Mager DL &
    4. Kooijman R

    2006 Prolactin in man: a tale of two promoters. BioEssays 28 1051–1055doi:10.1002/bies.20468.
32. ↵
    1. Giepmans BNG,
    2. Adams SR,
    3. Ellisman MH &
    4. Tsien RY

    2006 The fluorescent toolbox for assessing protein location and function. Science 312 217–224doi:10.1126/science.1124618.
33. ↵
    1. Guan Y,
    2. Dunham MJ &
    3. Troyanskaya OG

    2007 Functional analysis of gene duplications in Saccharomyces cerevisiae. Genetics 175 933–943doi:10.1534/genetics.106.064329.
34. ↵
    1. Harper CV,
    2. Featherstone K,
    3. Semprini S,
    4. Friedrichsen S,
    5. McNeilly J,
    6. Paszek P,
    7. Spiller DG,
    8. McNeilly AS,
    9. Mullins JJ,
    10. Davis JRE
    11. et al.

    2010 Dynamic organisation of prolactin gene expression in living pituitary tissue. Journal of Cell Science 123 424–430doi:10.1242/jcs.060434.
35. ↵
    1. Hasegawa K &
    2. Nakatsuji N

    2002 Insulators prevent transcriptional interference between two promoters in a double gene construct for transgenesis. FEBS Letters 520 47–52doi:10.1016/S0014-5793(02)02761-8.
36. ↵
    1. Hebbar PB &
    2. Archer TK

    2008 Altered histone H1 stoichiometry and an absence of nucleosome positioning on transfected DNA. Journal of Biological Chemistry 283 4595–4601doi:10.1074/jbc.M709121200.
37. ↵
    1. Conn PM

    1. Hendrickson EA

    2008 Gene targeting in human somatic cells. In Source Book of Models for Biomedical Research, pp 509–525. Ed. Conn PM. Totowa, NJ: Humana Press, Inc.
38. ↵
    1. Hirata RK &
    2. Russell DW

    2000 Design and packaging of adeno-associated virus gene targeting vectors. Journal of Virology 74 4612–4620doi:10.1128/JVI.74.10.4612-4620.2000.
39. ↵
    1. Hockemeyer D,
    2. Soldner F,
    3. Beard C,
    4. Gao Q,
    5. Mitalipova M,
    6. DeKelver RC,
    7. Katibah GE,
    8. Amora R,
    9. Boydston EA,
    10. Zeitler B
    11. et al.

    2009 Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nature Biotechnology 27 851–857doi:10.1038/nbt.1562.
40. ↵
    1. Howarth JL,
    2. Lee YB &
    3. Uney JB

    2010 Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells). Cell Biology and Toxicology 26 1–20doi:10.1007/s10565-009-9139-5.
41. ↵
    1. Huszar T,
    2. Mucsi I,
    3. Terebessy T,
    4. Masszi A,
    5. Adamko S,
    6. Jeney C &
    7. Rosivall L

    2001 The use of a second reporter plasmid as an internal standard to normalize luciferase activity in transient transfection experiments may lead to a systematic error. Journal of Biotechnology 88 251–258doi:10.1016/S0168-1656(01)00277-2.
42. ↵
    1. Ishikawa T,
    2. Lee EJ &
    3. Jameson JL

    2004 Nonhomologous end-joining ligation transfers DNA regulatory elements between cointroduced plasmids. Molecular and Cellular Biology 24 8323–8331doi:10.1128/MCB.24.19.8323-8331.2004.
43. ↵
    1. Ishikawa TO,
    2. Jain NK,
    3. Taketo MM &
    4. Herschman HR

    2006 Imaging cyclooxygenase-2 (Cox-2) gene expression in living animals with a luciferase knock-in reporter gene. Molecular Imaging and Biology 8 171–187doi:10.1007/s11307-006-0034-7.
44. ↵
    1. Jackson RJ &
    2. Standart N

    2007 How do microRNAs regulate gene expression? Science's STKE: Signal Transduction Knowledge Environment 2007 p.re1.
45. ↵
    1. Jenke BH,
    2. Fetzer CP,
    3. Stehle IM,
    4. Jonsson F,
    5. Fackelmayer FO,
    6. Conradt H,
    7. Bode J &
    8. Lipps HJ

    2002 An episomally replicating vector binds to the nuclear matrix protein SAF-A in vivo. EMBO Reports 3 349–354doi:10.1093/embo-reports/kvf070.
46. ↵
    1. Jenke ACW,
    2. Stehle IM,
    3. Herrmann F,
    4. Eisenberger T,
    5. Baiker A,
    6. Bode J,
    7. Fackelmayer FO &
    8. Lipps HJ

    2004 Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. PNAS 101 11322–11327doi:10.1073/pnas.0401355101.
47. ↵
    1. Jones BK,
    2. Monks BR,
    3. Liebhaber SA &
    4. Cooke NE

    1995 The human growth hormone gene is regulated by a multicomponent locus control region. Molecular and Cellular Biology 15 7010–7021.
48. ↵
    1. Kim TK &
    2. Eberwine JH

    2010 Mammalian cell transfection: the present and the future. Analytical and Bioanalytical Chemistry 397 3173–3178doi:10.1007/s00216-010-3821-6.
49. ↵
    1. Kim J-S,
    2. Bonifant C,
    3. Bunz F,
    4. Lane WS &
    5. Waldman T

    2008 Epitope tagging of endogenous genes in diverse human cell lines. Nucleic Acids Research 36 e127doi:10.1093/nar/gkn566.
50. ↵
    1. Kuhn EJ &
    2. Geyer PK

    2003 Genomic insulators: connecting properties to mechanism. Current Opinion in Cell Biology 15 259–265doi:10.1016/S0955-0674(03)00039-5.
51. ↵
    1. Lander ES,
    2. Linton LM,
    3. Birren B,
    4. Nusbaum C,
    5. Zody MC,
    6. Baldwin J,
    7. Devon K,
    8. Dewar K,
    9. Doyle M,
    10. FitzHugh W
    11. et al.

    2001 Initial sequencing and analysis of the human genome. Nature 409 860–921doi:10.1038/35057062.
52. ↵
    1. Lufino MMP,
    2. Manservigi R &
    3. Wade-Martins R

    2007 An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. Nucleic Acids Research 35 e98doi:10.1093/nar/gkm570.
53. ↵
    1. Lufino MM,
    2. Edser PA &
    3. Wade-Martins R

    2008 Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene expression. Molecular Therapy 16 1525–1538doi:10.1038/mt.2008.156.
54. ↵
    1. Magin-Lachmann C,
    2. Kotzamanis G,
    3. D'Aiuto L,
    4. Cooke H,
    5. Huxley C &
    6. Wagner E

    2004 In vitro and in vivo delivery of intact BAC DNA – comparison of different methods. Journal of Gene Medicine 6 195–209doi:10.1002/jgm.481.
55. ↵
    1. McCarty DM,
    2. Young SM &
    3. Samulski RJ

    2004 Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annual Review of Genetics 38 819–845doi:10.1146/annurev.genet.37.110801.143717.
56. ↵
    1. Mileyko Y &
    2. Weitz JS

    2010 Bifurcation analysis of gene regulatory circuits subject to copy number variation. SIAM Journal on Applied Dynamical Systems 9 799–826doi:10.1137/090771247.
57. ↵
    1. Mutskov V &
    2. Felsenfeld G

    2004 Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO Journal 23 138–149doi:10.1038/sj.emboj.7600013.
58. ↵
    1. Narayanan K

    2008 Intact recombineering of highly repetitive DNA requires reduced induction of recombination enzymes and improved host viability. Analytical Biochemistry 375 394–396doi:10.1016/j.ab.2008.01.022.
59. ↵
    1. Osten P,
    2. Grinevich V &
    3. Cetin A

    2007 Viral vectors: a wide range of choices and high levels of service. Handbook of Experimental Pharmacology 178 177–202doi:10.1007/978-3-540-35109-2_8.
60. ↵
    1. Oumard A,
    2. Qiao J,
    3. Jostock T,
    4. Li J &
    5. Bode J

    2006 Recommended method for chromosome exploitation: RMCE-based cassette-exchange systems in animal cell biotechnology. Cytotechnology 50 93–108doi:10.1007/s10616-006-6550-0.
61. ↵
    1. Palmiter RD &
    2. Brinster RL

    1986 Germ-line transformation of mice. Annual Review of Genetics 20 465–499doi:10.1146/annurev.ge.20.120186.002341.
62. ↵
    1. Pfeifer A

    2004 Lentiviral transgenesis. Transgenic Research 13 513–522doi:10.1007/s11248-004-2735-5.
63. ↵
    1. Piechaczek C,
    2. Fetzer C,
    3. Baiker A,
    4. Bode J &
    5. Lipps HJ

    1999 A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Research 27 426–428doi:10.1093/nar/27.2.426.
64. ↵
    1. Presser A,
    2. Elowitz MB,
    3. Kellis M &
    4. Kishony R

    2008 The evolutionary dynamics of the Saccharomyces cerevisiae protein interaction network after duplication. PNAS 105 950–954doi:10.1073/pnas.0707293105.
65. ↵
    1. Qiao J,
    2. Oumard A,
    3. Wegloehner W &
    4. Bode J

    2009 Novel tag-and-exchange (RMCE) strategies generate master cell clones with predictable and stable transgene expression properties. Journal of Molecular Biology 390 579–594doi:10.1016/j.jmb.2009.05.012.
66. ↵
    1. Qu Z,
    2. Thottassery JV,
    3. Van Ginkel S,
    4. Manuvakhova M,
    5. Westbrook L,
    6. Roland-Lazenby C,
    7. Hays S &
    8. Kern FG

    2004 Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors. Gene 327 61–73doi:10.1016/j.gene.2003.10.029.
67. ↵
    1. Rafalska-Metcalf IU &
    2. Janicki SM

    2007 Show and tell: visualizing gene expression in living cells. Journal of Cell Science 120 2301–2307doi:10.1242/jcs.008664.
68. ↵
    1. Rago C,
    2. Vogelstein B &
    3. Bunz F

    2007 Genetic knockouts and knockins in human somatic cells. Nature Protocols 2 2734–2746doi:10.1038/nprot.2007.408.
69. ↵
    1. Raser JM &
    2. O'Shea EK

    2004 Control of stochasticity in eukaryotic gene expression. Science 304 1811–1814doi:10.1126/science.1098641.
70. ↵
    1. Recillas-Targa F,
    2. Valadez-Graham V &
    3. Farrell CM

    2004 Prospects and implications of using chromatin insulators in gene therapy and transgenesis. BioEssays 26 796–807doi:10.1002/bies.20059.
71. ↵
    1. Rogers S,
    2. Wells R &
    3. Rechsteiner M

    1986 Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234 364–368doi:10.1126/science.2876518.
72. ↵
    1. Sabl JF &
    2. Henikoff S

    1996 Copy number and orientation determine the susceptibility of a gene to silencing by nearby heterochromatin in Drosophila. Genetics 142 447–458.
73. ↵
    1. Sakabe NJ &
    2. Nobrega MA

    2010 Genome-wide maps of transcription regulatory elements. Wiley Interdisciplinary Reviews. Systems Biology and Medicine 2 422–437doi:10.1002/wsbm.70.
74. ↵
    Sambrook J, Fritsch EF & Maniatis T 1989 In: Molecular Cloning: a laboratory manual, 2nd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, NY..
75. ↵
    1. Schlake T &
    2. Bode J

    1994 Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry 33 12746–12751doi:10.1021/bi00209a003.
76. ↵
    1. Sedivy JM,
    2. Vogelstein B,
    3. Liber HL,
    4. Hendrickson EA &
    5. Rosmarin A

    1999 Gene targeting in human cells without isogenic DNA. Science 283 9doi:10.1126/science.283.5398.9a.
77. ↵
    1. Semprini S,
    2. Troup TJ,
    3. Kotelevtseva N,
    4. King K,
    5. Davis JRE,
    6. Mullins LJ,
    7. Chapman KE,
    8. Dunbar DR &
    9. Mullins JJ

    2007 Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Research 35 1402–1410doi:10.1093/nar/gkl1108.
78. ↵
    1. Semprini S,
    2. Friedrichsen S,
    3. Harper CV,
    4. McNeilly JR,
    5. Adamson AD,
    6. Spiller DG,
    7. Kotelevtseva N,
    8. Brooker G,
    9. Brownstein DG,
    10. McNeilly AS
    11. et al.

    2009 Real-time visualization of human prolactin alternate promoter usage in vivo using a double-transgenic rat model. Molecular Endocrinology 23 529–538doi:10.1210/me.2008-0399.
79. ↵
    1. Shaner NC,
    2. Patterson GH &
    3. Davidson MW

    2007 Advances in fluorescent protein technology. Journal of Cell Science 120 4247–4260doi:10.1242/jcs.005801.
80. ↵
    1. Shizuya H,
    2. Birren B,
    3. Kim UJ,
    4. Mancino V,
    5. Slepak T,
    6. Tachiiri Y &
    7. Simon M

    1992 Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. PNAS 89 8794–8797doi:10.1073/pnas.89.18.8794.
81. ↵
    1. Smith JR,
    2. Maguire S,
    3. Davis LA,
    4. Alexander M,
    5. Yang F,
    6. Chandran S,
    7. ffrench-Constant C &
    8. Pedersen RA

    2008 Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration. Stem Cells 26 496–504doi:10.1634/stemcells.2007-0039.
82. ↵
    1. Song H,
    2. Chung S-K &
    3. Xu Y

    2010 Modeling disease in human ESCs using an efficient bac-based homologous recombination system. Cell Stem Cell 6 80–89doi:10.1016/j.stem.2009.11.016.
83. ↵
    1. Sparwasser T &
    2. Eberl G

    2007 BAC to immunology – bacterial artificial chromosome-mediated transgenesis for targeting of immune cells. Immunology 121 308–313doi:10.1111/j.1365-2567.2007.02605.x.
84. ↵
    1. Spiller DG,
    2. Wood CD,
    3. Rand DA &
    4. White MRH

    2010 Measurement of single-cell dynamics. Nature 465 736–745doi:10.1038/nature09232.
85. ↵
    1. Stehle IM,
    2. Scinteie MF,
    3. Baiker A,
    4. Jenke AC &
    5. Lipps HJ

    2003 Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication. Chromosome Research 11 413–421doi:10.1023/A:1024962308071.
86. ↵
    1. Takasuka N,
    2. White MRH,
    3. Wood CD,
    4. Robertson WR &
    5. Davis JRE

    1998 Dynamic changes in prolactin promoter activation in individual living lactotrophic cells. Endocrinology 139 1361–1368doi:10.1210/en.139.3.1361.
87. ↵
    1. Thomas H,
    2. Senkel S,
    3. Erdmann S,
    4. Arndt T,
    5. Turan Glz,
    6. Klein-Hitpass L &
    7. Ryffel GU

    2004 Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4α and HNF1β in a pancreatic β-cell line. Nucleic Acids Research 32 e150doi:10.1093/nar/gnh144.
88. ↵
    1. Topaloglu O,
    2. Hurley PJ,
    3. Yildirim O,
    4. Civin CI &
    5. Bunz F

    2005 Improved methods for the generation of human gene knockout and knockin cell lines. Nucleic Acids Research 33 e158doi:10.1093/nar/gni160.
89. ↵
    1. Townes TM,
    2. Lingrel JB,
    3. Chen HY,
    4. Brinster RL &
    5. Palmiter RD

    1985 Erythroid-specific expression of human beta-globin genes in transgenic mice. EMBO Journal 4 1715–1723.
90. ↵
    1. Tsien RY

    1998 The green fluorescent protein. Annual Review of Biochemistry 67 509–544doi:10.1146/annurev.biochem.67.1.509.
91. ↵
    1. Turan S,
    2. Kuehle J,
    3. Schambach A,
    4. Baum C &
    5. Bode J

    2010 Multiplexing RMCE: versatile extensions of the Flp-recombinase-mediated cassette-exchange technology. Journal of Molecular Biology 402 52–69doi:10.1016/j.jmb.2010.07.015.
92. ↵
    1. Venter JC,
    2. Adams MD,
    3. Myers EW,
    4. Li PW,
    5. Mural RJ,
    6. Sutton GG,
    7. Smith HO,
    8. Yandell M,
    9. Evans CA,
    10. Holt RA
    11. et al.

    2001 The sequence of the human genome. Science 291 1304–1351doi:10.1126/science.1058040.
93. ↵
    1. Verma IM &
    2. Weitzman MD

    2005 Gene therapy: twenty-first century medicine. Annual Review of Biochemistry 74 711–738doi:10.1146/annurev.biochem.74.050304.091637.
94. ↵
    1. Warming S,
    2. Costantino N,
    3. Court DL,
    4. Jenkins NA &
    5. Copeland NG

    2005 Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Research 33 e36doi:10.1093/nar/gni035.
95. ↵
    1. West AG &
    2. Fraser P

    2005 Remote control of gene transcription. Human Molecular Genetics 14 R101–R111doi:10.1093/hmg/ddi104.
96. ↵
    1. White MR,
    2. Masuko M,
    3. Amet L,
    4. Elliott G,
    5. Braddock M,
    6. Kingsman AJ &
    7. Kingsman SM

    1995 Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells. J Cell Sci 108 441–445.
97. ↵
    1. Wirth D,
    2. Gama-Norton L,
    3. Riemer P,
    4. Sandhu U,
    5. Schucht R &
    6. Hauser H

    2007 Road to precision: recombinase-based targeting technologies for genome engineering. Current Opinion in Biotechnology 18 411–419doi:10.1016/j.copbio.2007.07.013.
98. ↵
    1. Xu M &
    2. Cook PR

    2008 Similar active genes cluster in specialized transcription factories. Journal of Cell Biology 181 615–623doi:10.1083/jcb.200710053.
99. ↵
    1. Yáñez RJ &
    2. Porter ACG

    1999 Influence of DNA delivery method on gene targeting frequencies in human cells. Somatic Cell and Molecular Genetics 25 27–31doi:10.1023/B:SCAM.0000007137.28557.73.
100. ↵
     1. Yanez-Munoz RJ,
     2. Balaggan KS,
     3. MacNeil A,
     4. Howe SJ,
     5. Schmidt M,
     6. Smith AJ,
     7. Buch P,
     8. MacLaren RE,
     9. Anderson PN,
     10. Barker SE
     11. et al.

     2006 Effective gene therapy with nonintegrating lentiviral vectors. Nature Medicine 12 348–353doi:10.1038/nm1365.
101. ↵
     1. Zhang Y &
     2. Oliver B

     2007 Dosage compensation goes global. Current Opinion in Genetics and Development 17 113–120doi:10.1016/j.gde.2007.02.002.